Role of plasminogen activator-plasmin system in tumor angiogenesis
- PMID: 12737307
- PMCID: PMC11138537
- DOI: 10.1007/s000180300039
Role of plasminogen activator-plasmin system in tumor angiogenesis
Abstract
New blood formation or angiogenesis has become a key target in therapeutic strategies aimed at inhibiting tumor growth and other diseases associated with neovascularization. Angiogenesis is associated with important extracellular remodeling involving different proteolytic systems among which the plasminogen system plays an essential role. It belongs to the large serine proteinase family and can act directly or indirectly by activating matrix metalloproteinases or by liberating growth factors and cytokines sequestered within the extracellular matrix. Migration of endothelial cells is associated with significant upregulation of proteolysis and, conversely, immunoneutralization or chemical inhibition of the system reduces angiogenesis in vitro. On the other hand, genetically altered mice developed normally without overt vascular anomalies indicating the possibility of compensation by other proteases in vivo. Nevertheless, they have in some experimental settings revealed unanticipated roles for previously characterized proteinases or their inhibitors. In this review, the complex mechanisms of action of the serine proteases in pathological angiogenesis are summarized alongside possible therapeutic applications.
Similar articles
-
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337. Int J Mol Sci. 2021. PMID: 35008762 Free PMC article. Review.
-
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1104-17. doi: 10.1161/hq0701.093685. Arterioscler Thromb Vasc Biol. 2001. PMID: 11451738 Review.
-
Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.Enzyme Protein. 1996;49(1-3):138-62. doi: 10.1159/000468622. Enzyme Protein. 1996. PMID: 8797003 Review.
-
Extracellular proteolysis and angiogenesis.Thromb Haemost. 2001 Jul;86(1):346-55. Thromb Haemost. 2001. PMID: 11487024 Review.
-
Fibrinolysis: the key to new pathogenetic mechanisms.Curr Med Chem. 2008;15(9):923-9. doi: 10.2174/092986708783955455. Curr Med Chem. 2008. PMID: 18473800 Review.
Cited by
-
Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.Oncotarget. 2016 Jul 26;7(30):47720-47737. doi: 10.18632/oncotarget.10279. Oncotarget. 2016. PMID: 27351226 Free PMC article.
-
Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogen.Cancer Immunol Immunother. 2010 Dec;59(12):1885-93. doi: 10.1007/s00262-010-0915-0. Epub 2010 Sep 2. Cancer Immunol Immunother. 2010. PMID: 20811885 Free PMC article.
-
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337. Int J Mol Sci. 2021. PMID: 35008762 Free PMC article. Review.
-
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.BMC Cancer. 2008 Jan 28;8:25. doi: 10.1186/1471-2407-8-25. BMC Cancer. 2008. PMID: 18226209 Free PMC article.
-
Cell surface remodeling by plasmin: a new function for an old enzyme.J Biomed Biotechnol. 2012;2012:564259. doi: 10.1155/2012/564259. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23097597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources